Preliminary Scientific Programme - Monday 9 June

8.30-10.15
Room: Bordeaux
Company Sponsored Symposium 4

ALK-Abelló

ALLERGY VACCINATION: CURING ALLERGY - PREVENTING ASTHMA

Chairpersons:
G Walter Canonica, Italy
Stephen T Holgate, United Kingdom

The UK initiative - documenting allergy vaccination
Anthony J Frew, United Kingdom

Curing allergy and preventing asthma
Giovanni B. Pajno, Italy

Immunological mechanisms and future perspectives of sublingual immunotherapy
Christof Ebner, Austria

Best practices of allergy vaccination and sublingual immunotherapy
Lars Jacobsen, Denmark


Room: Bleu
Main Symposium 10

EPIDEMIOLOGY OF ALLERGIC DISEASES

Chairpersons:
Ted Popov, Bulgaria
Isabella Annesi-Maesano, France

Rhinitis and asthma coexist in adults, lessons from ECRHS
Bénédicte Leynaert, France

What are the interactions between rhinitis and asthma in children? Lessons from ISAAC
Isabella Annesi-Maesano, France

Are there genetic differences between asthma and rhinitis? Lessons from EGEA
Marie-Hélène Dizier, France

Is farming preventive of allergy and asthma?
Erika von Mutius, Germany


Room: Havane
Main Symposium 11

ALLERGIC AND NON-ALLERGIC ASTHMA

Chairpersons:
Jan Lötvall, Sweden
Antoine Magnan, France

Is allergy really important in asthma?
Klaus Rabe, The Netherlands

Bronchial IgE production in intrinsic asthma
Marc Humbert, France

Is allergen challenge representative of natural exposure and disease?
Frederic de Blay, France

Aspirin induced asthma - a systemic disease
Marek Kowalski, Poland


Room 352 AB
Main Symposium 12

URTICARIA/ANGIOEDEMA

Chairpersons:
Alexander Kapp, Germany
Gérard Guillet, France

Clinical spectrum and diagnostic guidelines
Clive Grattan, United Kingdom

Trigger factors: infections, food additives or what?
Bettina Wedi, Germany

Acquired angioedema by C1 INH deficiency
Marie-Thérèse Guinnepain, France

Is there a new treatment?
Carsten Bindslev-Jensen, Denmark


Room: 242 AB
EAACI/ACAAI Joint Symposium

Chairpersons:
William Berger, United States
Sergio Del Giacco, Itayl

UEMS
Sergio Del Giacco, Italy

CME activities in Europe
G Walter Canonica, Italy/Fulvio Braido, Italy

The CME pricess in the United States
Myron Zitt, United States

How clinical research is conducted in the United States
Bob Lanier, United States


Room: 252 AB
Mini Symposium 2

PAEDIATRIC ASTHMA

Chairperson:
Kai-Haakon Carlsen, Norway
Co-chair:
Christophe Delacourt, France

Introductory lecturer - Asthma from infancy to adulthood
Kai-Haakon Carlsen, Norway


Room: 342 A
Oral Abstract Session 6

RHINITIS MECHANISMS

Chairpersons:
Roy Gerth van Wijk, The Netherlands
Jean-Michel Klossek, France


10.30-12.15
Grand Amphithéâtre
Plenary Session 2

THE ALLERGY MARCH

Chairpersons:
Gabrielle Pauli, France
Marek L. Kowalski, Poland

The development of atopic phenotypes in infancy and childhood
Ulrich Wahn, Germany

Can allergy be prevented?
Adnan Custovic, United Kingdom

Why do allergic diseases persist?
Hans-Uwe Simon, Switzerland

What are the long-term consequences of asthma?
A Maurizio Vignola, Italy


12.30-13.30
Room: Bleu
EAACI General Assembly & Council of National Societies

The General Assembly is the governing body of the Academy. EAACI members are encouraged to actively participate in this meeting and present thier views. This year the General Assembly will be electing a new Board of Officers and Members at Large for the period 2003-2005. We encourage members to arrive on time as we will begin promtly at 12.30 on Monday 9 June in the Amphithéâtre Bleu at the Congress Centre. Please bring your EAACI membership card with you to gain entry to this meeting.


12.30-13.30
Meet the Professors Seminars

An opportunity for focussed discussion
with experts in the field. Register for the
seminars on the registration form.

Room: 243
7 Steroid Dependent Asthma
Pascal Chanez, France + A Maurizio Vignola, Italy

Room: 253
8 Atopic Dermatitis in Infants
Aude Nassif, France + Yves De Prost, France

Room: 343
9 Occupational Rhinitis
CANCELLED

Room: 351
10 Mediterranean Allergy
Denis Charpin, France + Gennaro D'Amato, Italy

Room: 241
11 Genetics of Asthma
Florence Demenais, France + Marie-Hélène Dizier, France

Room: 342 B
12 Primary Prevention of Allergy
Pierre Scheinmann, France + Adnan Custovic, United Kindom


12.45-13.30
Grand Amphithéâtre
Pro & Con Session 2

ARE ANTI-LEUKOTRIENES USEFUL IN ASTHMA?

Two experts will present their different
views on a controversial issue. The audience
is encouraged to join the discussion.

Moderators:
Pierre Duroux, France
K Fan Chung, Untited Kingdom

Pro: Stephen Holgate, United Kingdom
Con: Peter J Barnes, United Kingdom


13.30-15.15
Room: Bourdeaux
Company Sponsored Symposium 5

UCB
EVIDENCE-BASED TREATMENT STRATEGY FOR
ALLERGIC RHINITIS

Chairperson:
Jean Bousquet, France

Nose symptoms and disease perception in allergic rhinitis
Giovanni Passalacqua, Italy

Histamine induced symptoms in controlled environments
Norbert Krug, Germany

A Global approach to the treatment of persistent rhinitis: XPERT results
Claus Bachert, Belgium

Combination therapy in the unified airway
Brian Lipworth, United Kingdom


Room: Bleu
Main Symposium 13

EAACI-AAAAI SYMPOSIUM

Chairpersons:
Hans-Jørgen Malling, Denmark
Lanny J. Rosenwasser, United States

Novel approaches to immunotherapy for allergic reactions to foods
Hugh Sampson, United States

Genetic engineering of the Parietaria allergens
Paolo Colombo, Italy

Congugate immunotherapy
Eyal Raz, United States

T-cell peptide SIT
Mark Larché, United Kingdom


Room: Havane
Main Symposium 14

PAEDIATRICS 2: DIFFICULT-TO-TREAT ASTHMA IN CHILDHOOD

Chairpersons:
Pierre Scheinmann, France
Bodo Niggemann, Germany

Severe viral infection in infancy as a predictor of asthma in childhood
Bengt Björkstén, Sweden

Bronchial inflammation in difficult-totreat asthma in children
Jacques de Blic, France

Treatment of severe asthma in young children
Hans Bisgaard, Denmark

Middle and long term outcome of severe infant wheezing
Alain Grimfeld, France


Room: 241
Poster Discussion Session 5

FOOD CHALLANGES

Moderators:
Jonathan Hourihane, United Kingdom
Fabienne Rancé, France


Room: 251
Poster Discussion Session 6

AUTOIMMUNITY AND IMMUNODEFICIENCIES

Moderators:
Volker Wahn, Germany
Marek L Kowalski, Poland


Room: 351
Poster Discussion Session 7

DRUG ALLERGY DIAGNOSIS

Moderators:
Pascal Demoly, France
Antonio Romano, Italy


Room: 342 A
Poster Discussion Session 8

OUTDOOR AND INDOOR POLLUTION

Moderators:
Gennaro D'Amato, Italy
Frederic de Blay, France


15.30-17.15
Room: Bourdeaux
Company Sponsored Symposium 6

GlaxoSmithKline

ACHIEVING CONTROL OF PERSISTENT ASTHMA

Chairman:
Eric Bateman, South Africa

Chairman's introduction
Eric Bateman, South Africa

Mild asthma - myth or reality?
David Stempel, United States

Pathophysiology of persistent asthma
Ashley Woodcock, United Kingdom

Persistent asthma: how to assess control
Claes-Göran Löfdahl, Sweden

Treatment options for optimal control
Philippe Devillier, France

Chairman's summary and close
Eric Bateman, South Africa


Room: Havane
Main Symposium 15

IMMUNOLOGICAL BASIS FOR NOVEL TREATMENTS IN ALLERGY

Chairpersons:
Hans-Uwe Simon, Switzerland
Manuel Tunon-de-Lara, France

Cytokines and anti-cytokines
Harald Renz, Germany

PPAR gamma, a new target for antiasthma drugs
Marina Pretolani, France

Activation and polarisation of T cells and dendritic cells
Federica Sallusto, Switzerland

Apoptosis
Mübeccel Akdis, Switzerland


Room: Bleu
Main Symposium 16

ALLERGIC RHINITIS, PART OF A SYSTEMIC DISEASE

Chairpersons:
Claus Bachert, Belgium
Joaquim Mullol-Miret, Spain

Glucocorticoid receptor in the nose and the lungs
Joaquim Mullol-Miret, Spain

Asthma diagnosis in patients suffering from rhinitis
Pascal Demoly, France

Effect of local and systemic treatment of allergic rhinitis on the lower airways
Sabina Rak, Sweden

What do we learn from a murine model of allergic airway disease
Peter Hellings, Belgium


Room: 352 AB
IRINE Symposium

ADVANCES IN CLINCAL AND EXPERIMENTAL ALLERGY

Chairpersons:
Kristof Nekam, Hungary
Lawrence du Buske, United States

Advances in the understanding of aspirin-sensitive asthma
Andrew Szczeklik, Poland

Inflammatory markers in exhaled breath condensates
Ildiko Horvath, Hungary

Effects of ozone on the nasal mucosa
Dejan Dokic, Macedonia

Role of Major Histo-compatibility molecules in the determination of apoptosis in allergic disease
Igor Kaidashev, Ukraine

Histamine and histamine receptors in modulation of IgE production
Roman Khanferyan, Russia

IRINE multicenter study of latex allergy in eastern Europe
Lawrence Du Buske, United States


Room: 242 AB
Oral Abstract Session 7

CELLULAR AND MOLECULAR MECHANISMS UNDERLYING ASTHMA PATHOGENESIS

Chairpersons:
Anne Tsicopoulos, France
Ratko Djukanovic, United Kingdom


Room: 252 AB
Oral Abstract Session 8

FOOD ALLERGENS

Chairpersons:
Ronald van Ree, The Netherlands
Cristoph Ebner, Austria


Room: 342 A
Oral Abstract Session 9

INFECTIONS AND ALLERGY

Chairpersons:
Sebastian Johnston, United Kingdom
Paolo M. Matricardi, Italy


17.30-19.00
Room: Bordeaux
Satellite Symposium - UCB

NEW FRONTIERS IN ALLERGY THERAPY

Chairperson:
Gabrielle Pauli, France

Enantiomers : a natural evolution
Camille G. Wermuth, France

Role of histamine models in evaluating the activity of antihistamines
Gabrielle Pauli, France

Clinical efficacy of antihistamines using a controlled pollen exposure system: a comparison of desloratadine and levocetirizine
James Day, Canada

Role of new antihistamines in allergy
Serge Kouzan, Belgium


Room: 252 AB
Satellite Symposium - Almirall

UNMET NEEDS IN ALLERGIC RHINITIS

Chairpersons:
Jean Bousquet, France
Cesar Picado, Spain

Can the allergic march be prevented?
Ulrich Wahn, Germany

Is the classification of AR clear?
Pascal Demoly, France

What is the safety of H1 blockers
Paul van Cauwenberge, Belgium

Patient satisfaction
Glenis Scadding, United Kingdom


Room: Havane
Satellite Symposium - Bayer AG

RECENT ADVANCES IN INTRAVENOUS IMMUNOGLOBULIN THERAPY

Chairperson:
Janne Björkander, Sweden

Welcome and Introduction: An overview of intravenous immunoglobulin therapy
Janne Björkander, Sweden

Confronting the new challenges in blood product pathogen safety
Dominique Pifat, United States

Clinical studies in PID with a new chromatography-purified intravenous immunoglobulin
Volker Wahn, Germany

Can differences in intravenous immunoglobulin production impact outcome?
All intravenous immunoglobulins are not the same!
Erwin Gelfand, United States

Final discussion

Closing remarks
Janne Björkander, Sweden


Room: 242 AB
Satellite Symposium - Alcon Laboratories Inc.

OCULAR ALLERGY SYMPOSISUM - ALLERGIES DON'T STOP AT THE NOSE - A REVIEW OF OCULAR ALLERGIES & THERAPEUTIC OPTIONS

Chairperson:
Sergio Bonini, Italy

Allergy - A Global Approach
G Walter Canonica, Italy

Diagnostic & Therapeutic Flow Charts
Stefano Bonini, Italy

Differential Diagnosis of Ocular Allergy
Stephen Foster, United States

New Treatment Options for Allergic Conjunctivitis
Dennis Spangler, United States